[1]Mller S,Henriksen JH.Cardiovascular complications ofcirrhosis[J].Postgrad Med J,2009,85(999):44-54.
|
[2]叶乐驰,张启瑜.门静脉高压症内脏血管扩张机制的研究进展[J].国际外科学杂志,2006,33(1):7-11.
|
[3]Henriksen JH,M?ller S.Cardiac and systemic hae-modynamic complications of liver cirrhosis[J].ScandCardiovasc J,2009,43(4):218-225.
|
[4]Large DA,Shah VH.Nitric oxide and portal hypertension:interface of vasoreactivity and angiogenesis[J].J Hepatol,2006,44(1):209-216.
|
[5]Rockey DC.Hepatic blood flow regulation by stellatecells in normal and injured liver[J].Semin Liver Dis,2001,21(3):337-349.
|
[6]Wiest R,Groszmann RJ.The paradox of nitric oxide incirrhosis and portal hypertension:too much,not enough[J].Hepatology,2002,35(2):478-491.
|
[7]M?ller S,Bendtsen F,Christensen E,et al.Prognosticvariables in patients with cirrhosis and oesophageal variceswithout prior bleeding[J].J Hepatol,1994,21(6):940-946.
|
[8]Rodríguez-Roisin R,Krowka MJ,HervéP,et al.Pul-monary-Hepatic vascular Disorders(PHD)[J].Eur Respir J,2004,24(5):861-880.
|
[9]Rodriguez-Roisin R,Krowka MJ.Hepatopulmonarysyndrome-a liver-induced lung vascular disorder[J].N EnglJ Med,2008,358(22):2378-2387.
|
[10]Philippe H,Jerome LP,Benjamin S,et al.Pulmonaryvascular abnormalities in cirrhosis[J].Best Pratt Res ClinGastroenterol,2007,21(1):141-159.
|
[11]Vincent Ho.Current concepts in the management ofhepatopulmonary syndrome[J].Vasc Health Risk Manag,2008,4(5):1035-1041.
|
[12]Turban S,Thuluvath PJ,Atta MG.Hepatorenal syndrome[J].World J Gastroenterol,2007,13(30):4046-4055.
|
[13]Arroyo V,Terra C,Ginès P.Advances in the pathogenesisand treatment of type-1 and type-2 hepatorenalsyndrome[J].J Hepatol,2007,46(5):935-946.
|
[14]Blei AT.Monitoring cerebral blood flow:a useful clinical tool in acute liver failure?[J].Liver Transpl,2005,11(11):1320-1322.
|
[15]Iwakiri Y,Groszmann RJ.The hyperdynamic circulation ofchronic liver diseases:from the patient to the molecule[J].Hepatology,2006,43(2 Suppl 1):S121-131.
|
[16]Iversen P,S?rensen M,Bak LK,et al.Low cerebral ox-ygen consumption and blood flow in patients with cirrhosisand an acute episode of hepatic encephalopathy[J].Gastroenterology,2009,136(3):863-871.
|
[17]Gines P,Arroyo V,Rodes J,et al.Ascites and renaldysfunction in liver disease:Pathogenesis,Diagnosis,andTreatment[M].Malden:Blackwell,2005:139-155.
|
[18]Carrella M,Hunter JO,Fazio S,et al.Capillary blood flowto the skin of forearm in cirrhosis[J].Angiology,1992,43(12):969-974.
|
[19]Maroto A,Ginès P,Arroyo V,et al.Brachial and femoralartery blood flow in cirrhosis:relationship to kidneydysfunction[J].Hepatology,1993,17(5):788-793.
|
[20]Luca A,Garcia-Pagan JC,Feu F,et al.Noninvasivemeasurement of femoral blood flow and portal pressureresponse to propranolol in patients with cirrhosis[J].Hepatology,1995,21(1):83-88.
|
[1] | Wang HongSha, Wei Qi, Lei ManMan, Jin QingLong, Wen XiaoYu, Guo YuYing. Acute hepatitis B complicated by EB virus infection: a case report[J]. Journal of Clinical Hepatology, 2017, 33(4): 725-727. doi: 10.3969/j.issn.1001-5256.2017.04.026 |
[2] | Zhu Peng, Tang Yi, Wang YuMing. Recommendations for APASL Clinical Practice Guidelines: management of hepatitis B (updated in 2015)[J]. Journal of Clinical Hepatology, 2016, 32(3): 423-428. doi: 10.3969/j.issn.1001-5256.2016.03.004 |
[3] | Li Jun. Clinical research progress in integrated traditional Chinese and Western medicine therapy for HBV-related liver failure[J]. Journal of Clinical Hepatology, 2015, 31(1): 42-47. doi: 10.3969/j.issn.1001-5256.2015.01.010 |
[4] | Sun YuMei, Zhou YingXia, Xing HuiChun, Lin KeKe. Clock drawing test in cognitive assessment for patients with hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 413-417. doi: 10.3969/j.issn.1001-5256.2015.03.024 |
[5] | Xu Ying, Liu Yu, Sun Jian. Key points of the AASLD′s guidelines on hepatitis B diagnosis and treatment[J]. Journal of Clinical Hepatology, 2013, 29(2): 162-169. |
[6] | Yan Tao, Li Fan, Li Ke, Zhao Ping, Wang HuiFen. Analysis of mutational patterns of the pre-C/C region of with hepatitis B virus in patients with HBV-associated acute-on-chronic liver failure [J]. Journal of Clinical Hepatology, 2013, 29(2): 120-123+127. |
[7] | Jiang LiSheng, Li YongGuo, Chen Shu, Lan YingHua. Short-term and long-term efficacy of antiviral treatment of patients with HBV-associated acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2013, 29(2): 110-113. |
[8] | Cao Xiao, Cao QingBao, Zhang GuoQiang, Chang ZaiJuan, Li ShuPing, Xu WeiWei. Analysis of occult hepatitis B virus infection among blood donors in Tangshan, China[J]. Journal of Clinical Hepatology, 2013, 29(2): 117-119. |
[9] | Zhang Tao, Sun KeWei. Experience and progresses of Chinese medicine therapy for hepatitis B-associated liver failure[J]. Journal of Clinical Hepatology, 2012, 28(3): 169-171+182. |
[10] | Peng JianPing, Sun KeWei, Wu YuNan. Impact of early virological response to antiviral treatment on the outcomes of hepatitis B-associated liver failure [J]. Journal of Clinical Hepatology, 2012, 28(10): 752-755. |
[11] | Wang XiaoJing, Ning Qin. Prospect and progression on severe acute exacerbation of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2012, 28(6): 401-404+412. |
[12] | Hu XiaoLi, Zhao HongWei, Wu XiaoYan, Niu JunQi. Prevalence of hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2012, 28(6): 413-416+421. |
[13] | Deng Le, Wen ZhiLi. Review of recent research progress in correlating HBV genotypes with efficacy of antiviral treatments[J]. Journal of Clinical Hepatology, 2012, 28(6): 469-473. |
[14] | Gao Zhen, Zhang LunLi. Toll like receptors mediated innate immune responses against HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(6): 667-669+673. |
[15] | Yuan JianGuo, Wang XinGuo, Cui Xia, Liu FengHua, Wang FengHua, Song JiKui, Zhao HongKui. The activation of rat hepatic stellate cells stimulated with hepatitis B virus in vitro[J]. Journal of Clinical Hepatology, 2011, 27(2): 163-165. |
[16] | Zhao YanJuan, Ye ChunYan, Song XiaoDan. The change in serum thyroid hormone levels in acute hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(2): 161-162+165. |
[17] | Gu MaoLin, Wang XingLiang, Wu TingTing. Detection of HBV-LP and relationships between HBV DNA and its level in HBV patients with different patterns of HBV Markers[J]. Journal of Clinical Hepatology, 2011, 27(8): 810-812. |
[18] | Yu Hui. Advances in epidemiology, diagnosis and treatment of hepatitis B in children[J]. Journal of Clinical Hepatology, 2011, 27(7): 687-689. |
[19] | Liu Li, Hu XiaoXuan. A report of severe hepatitis with wilson desease and hepatitis B[J]. Journal of Clinical Hepatology, 2010, 26(6): 657+66. |
[20] | Shi YanMei, Lan YingHua, Dan Lei, Zhou Jin, Li YongGuo. The relationship between of hematopoietic stem cells and hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(4): 377-380. |